We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
(+18%)
Cap. Flow
+$342M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$163M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$137M |
| 3 |
Repligen
RGEN
|
+$104M |
| 4 |
Biogen
BIIB
|
+$104M |
| 5 |
Zoetis
ZTS
|
+$91.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$173M |
| 2 |
Agilent Technologies
A
|
+$137M |
| 3 |
Fidelity National Information Services
FIS
|
+$86.2M |
| 4 |
Adobe
ADBE
|
+$76.2M |
| 5 |
Keurig Dr Pepper
KDP
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.24% |
| 2 | Consumer Discretionary | 12.89% |
| 3 | Financials | 10.77% |
| 4 | Technology | 9.62% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Cummins
CMI
$91.7B
| $9.9M | 0.05% |
43,586
+38,815
| +814% | +$8.72M |
|
|
CIICW
352
CALL
DELISTED
CIIG Merger Corp. Warrants
CIICW
| $9.84M | 0.05% |
+349,997
| New | +$1.32M |
|
353
Schrodinger
SDGR
$1.12B
| $9.83M | 0.05% |
+124,119
| New | +$7.8M |
|
|
ENV
354
DELISTED
ENVESTNET, INC.
ENV
| $9.8M | 0.05% |
119,062
-17,753
| -13% | -$1.43M |
|
355
Spyre Therapeutics
SYRE
$8.87B
| $9.78M | 0.05% |
49,730
+33
| +0.1% | +$6.84K |
|
356
Toronto Dominion Bank
TD
$198B
| $9.78M | 0.05% |
173,167
-14,975
| -8% | -$759K |
|
|
BSN
357
DELISTED
Broadstone Acquisition Corp.
BSN
| $9.72M | 0.05% |
+967,413
| New | +$9.49M |
|
358
H&R Block
HRB
$5.18B
| $9.71M | 0.05% |
612,510
-561,321
| -48% | -$9.69M |
|
359
Knowles
KN
$3.22B
| $9.67M | 0.05% |
524,844
-199,414
| -28% | -$3.33M |
|
360
Omnicom Group
OMC
$22.7B
| $9.65M | 0.05% |
154,713
-108,178
| -41% | -$6.18M |
|
361
NVIDIA
NVDA
$5.01T
| $9.65M | 0.05% |
739,000
-933,720
| -56% | -$12.5M |
|
362
McCormick & Company Non-Voting
MKC
$13.4B
| $9.62M | 0.05% |
100,601
-243,831
| -71% | -$23M |
|
363
LKQ Corp
LKQ
$6.58B
| $9.54M | 0.05% |
270,582
-751,279
| -74% | -$25.7M |
|
|
CEO
364
DELISTED
CNOOC Limited
CEO
| $9.46M | 0.05% |
103,160
-2,735
| -3% | -$270K |
|
365
Virtu Financial
VIRT
$5.2B
| $9.44M | 0.05% |
375,042
-50,367
| -12% | -$1.17M |
|
|
SRTA
366
Strata Critical Medical Inc
SRTA
$436M
| $9.44M | 0.05% |
851,708
+351,710
| +70% | +$3.59M |
|
367
Synchrony
SYF
$23.7B
| $9.27M | 0.05% |
267,118
-6,752
| -2% | -$203K |
|
|
CAP.U
368
DELISTED
Capitol Investment Corp. V Units, each consisting of one share of Class A common stock, and one-thir
CAP.U
| $9.27M | 0.05% |
+900,000
| New | +$9.18M |
|
369
Credicorp
BAP
$30.9B
| $9.22M | 0.05% |
56,206
-3,583
| -6% | -$497K |
|
|
CELL
370
DELISTED
PhenomeX Inc. Common Stock
CELL
| $9.21M | 0.05% |
+103,059
| New | +$8.67M |
|
|
ME
371
DELISTED
23andMe Holding Co
ME
| $9.14M | 0.05% |
+39,999
| New | +$8.95M |
|
372
Royal Bank of Canada
RY
$291B
| $9.07M | 0.05% |
110,419
-667,954
| -86% | -$51.7M |
|
373
iShares US Real Estate ETF
IYR
$4.59B
| $9.03M | 0.05% |
105,445
+49,876
| +90% | +$4.15M |
|
374
iShares China Large-Cap ETF
FXI
$4.31B
| $9.02M | 0.05% |
+194,220
| New | +$8.87M |
|
375
Zai Lab
ZLAB
$2.17B
| $9.02M | 0.05% |
+66,617
| New | +$6.78M |
|
Similar funds
Marshall Wace's Q4 2020 Portfolio in Review
As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
- Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
- Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
- Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
- Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
- Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
- Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.
Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.